THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A
Advanced Science · 2026-11 · 13 (63)
DOI: 10.1002/advs.77422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.08.2026. Verfasst von Jiankun Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Aging and Vascular Diseases, Human Aging Research Institute and School of Life Science, Nanchang University, Jiangxi Key Laboratory of Aging and Dise…. Hauptthemen laut MEDLINE: Atherosclerosis, Integrin alphaVbeta3, Interleukin-1alpha. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Program of the National Natural Science Foundation of China, Jiangxi Province Key Laboratory of Aging and Disease.
Abstract (Originalsprache)
Our previous genome‐wide screening has linked THSD7A (thrombospondin type 1 domain containing 7A) gene to human coronary artery disease (CAD). How THSD7A contributes to atherosclerosis, however, remains unclear. In this study, we show THSD7A is increased in human carotid arteries and mouse atherosclerotic plaques. In apolipoprotein E knockout ( ApoE −/− ) mice, the overexpression of THSD7A increases monocyte‐endothelial adhesion and macrophage infiltration, exacerbating atherosclerotic lesions, whereas Thsd7A knockout ( Thsd7A −/− ) attenuates these phenotypic changes. Integrated single‐cell and bulk transcriptomic profiles demonstrate that THSD7A activates IL1A (Interleukin 1 alpha) signaling, augmenting endothelial inflammation. Mechanistically, THSD7A binds to integrin αvβ3, and such binding activates ERK (Extracellular signal‐regulated kinase) and augments IL1A ‐associated proinflammatory signaling. Notably, IL1A serves as a transcriptional target of CEBPD (CCAAT/enhancer‐binding protein delta), and CEBPD knockdown rescues THSD7A‐ mediated endothelial inflammation. These findings establish THSD7A as a novel and critical mediator in the regulation of the αvβ3/CEBPD/IL1A axis that controls endothelial inflammatory responses associated with atherosclerosis and demonstrate the importance of CEBPD as a downstream molecule in mediating THSD7A ‐associated signaling. This study positions THSD7A as both a genetic marker and a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aging and Vascular Diseases, Human Aging Research Institute and School of Life Science, Nanchang University, Jiangxi Key Laboratory of Aging and Diseases, Nanchang, China.
- Vascular Function Laboratory, Human Aging Research Institute and School of Life Science, Nanchang University, Jiangxi Key Laboratory of Human Aging, Nanchang, China.
ORCID-Profile: Jiankun Liu, Hongfei Liu, Xueting Gong, Ya Zhao, Weixin Lv, Xueer Li, Xiao-Li Tian
Förderung
- Key Program of the National Natural Science Foundation of China
- Jiangxi Province Key Laboratory of Aging and Disease
Zitieren
APA
Liu, J., Liu, H., Wan, Y., Wu, A., Qiu, J., Gong, X., Zhao, Y., Li, Y., Zhou, B., Zheng, Y., Wu, F., Zhu, Y., Lv, W., Li, X., Yuan, Q., & Tian, X. L. (2026). THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A. Advanced Science, 13(63). https://doi.org/10.1002/advs.77422
Vancouver
Liu J, Liu H, Wan Y, Wu A, Qiu J, Gong X, et al. THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A. Advanced Science. 2026;13(63). doi:10.1002/advs.77422
BibTeX
@article{Liu2026,
author = {Liu, Jiankun and Liu, Hongfei and Wan, Yiqi and Wu, Andong and Qiu, Jiayu and Gong, Xueting and Zhao, Ya and Li, Yuanyuan and Zhou, Bingbing and Zheng, Yangyi and Wu, Fang and Zhu, Yuanzheng and Lv, Weixin and Li, Xueer and Yuan, Qiang and Tian, Xiao-Li},
title = {THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {63},
doi = {10.1002/advs.77422}
}
EUVIMED